Key Financial Data Of Reporting Company

KYORIN Pharmaceutical Co., Ltd. - Filing #7330327

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
105,157,000,000 JPY
119,532,000,000 JPY
JPY
113,270,000,000 JPY
JPY
105,534,000,000 JPY
JPY
102,904,000,000 JPY
JPY
109,983,000,000 JPY
Operating revenue
JPY
5,853,000,000 JPY
6,575,000,000 JPY
7,189,000,000 JPY
7,244,000,000 JPY
Ordinary profit (loss)
7,417,000,000 JPY
6,602,000,000 JPY
2,975,000,000 JPY
5,827,000,000 JPY
3,960,000,000 JPY
5,569,000,000 JPY
4,585,000,000 JPY
6,447,000,000 JPY
4,482,000,000 JPY
8,175,000,000 JPY
Profit (loss)
52,995,000,000 JPY
3,005,000,000 JPY
3,919,000,000 JPY
4,516,000,000 JPY
4,476,000,000 JPY
Share capital
700,000,000 JPY
700,000,000 JPY
700,000,000 JPY
700,000,000 JPY
700,000,000 JPY
Total number of issued shares
64,607,936 xbrli:shares
64,607,936 xbrli:shares
64,607,936 xbrli:shares
64,607,936 xbrli:shares
64,607,936 xbrli:shares
Net assets
130,783,000,000 JPY
119,409,000,000 JPY
64,935,000,000 JPY
125,461,000,000 JPY
124,507,000,000 JPY
64,952,000,000 JPY
124,661,000,000 JPY
64,812,000,000 JPY
122,710,000,000 JPY
64,642,000,000 JPY
Total assets
177,679,000,000 JPY
163,527,000,000 JPY
99,304,000,000 JPY
176,045,000,000 JPY
171,924,000,000 JPY
95,619,000,000 JPY
167,126,000,000 JPY
95,391,000,000 JPY
171,160,000,000 JPY
95,126,000,000 JPY
Net assets per share
2,276.52
2,078.28
1,118.53
2,189.40
2,172.83
1,118.83
2,175.52
1,116.42
2,142.07
1,113.61
Dividend paid per share
52
52
52
75
75
Interim dividend paid per share
20
20
20
30
30
Basic earnings (loss) per share
923.33
92.74
51.78
82.44
67.51
68.62
77.80
106.99
77.11
107.35
Diluted earnings per share
Equity-to-asset ratio
0.736 xbrli:pure
0.730 xbrli:pure
0.654 xbrli:pure
0.713 xbrli:pure
0.724 xbrli:pure
0.679 xbrli:pure
0.746 xbrli:pure
0.679 xbrli:pure
0.717 xbrli:pure
0.680 xbrli:pure
Rate of return on equity
0.575 xbrli:pure
0.042 xbrli:pure
0.046 xbrli:pure
0.038 xbrli:pure
0.060 xbrli:pure
0.032 xbrli:pure
0.070 xbrli:pure
0.050 xbrli:pure
0.069 xbrli:pure
0.050 xbrli:pure
Price-earnings ratio
1.96 xbrli:pure
19.54 xbrli:pure
32.91 xbrli:pure
20.67 xbrli:pure
26.32 xbrli:pure
25.90 xbrli:pure
24.78 xbrli:pure
18.02 xbrli:pure
28.50 xbrli:pure
20.48 xbrli:pure
Payout ratio
0.057 xbrli:pure
1.006 xbrli:pure
0.772 xbrli:pure
0.966 xbrli:pure
0.974 xbrli:pure
Net cash provided by (used in) operating activities
1,549,000,000 JPY
2,008,000,000 JPY
6,346,000,000 JPY
5,189,000,000 JPY
7,739,000,000 JPY
Net cash provided by (used in) investing activities
-3,187,000,000 JPY
-6,275,000,000 JPY
-2,560,000,000 JPY
-4,259,000,000 JPY
-2,943,000,000 JPY
Net cash provided by (used in) financing activities
-3,347,000,000 JPY
-3,363,000,000 JPY
-4,112,000,000 JPY
-4,918,000,000 JPY
-5,117,000,000 JPY
Cash and cash equivalents
13,886,000,000 JPY
18,816,000,000 JPY
26,289,000,000 JPY
26,476,000,000 JPY
30,509,000,000 JPY
Number of employees
2,042 xbrli:pure
1,353 xbrli:pure
117 xbrli:pure
2,138 xbrli:pure
2,222 xbrli:pure
115 xbrli:pure
2,243 xbrli:pure
114 xbrli:pure
2,271 xbrli:pure
113 xbrli:pure
Total shareholder return
0.980 xbrli:pure
0.906 xbrli:pure
0.916 xbrli:pure
0.962 xbrli:pure
1.052 xbrli:pure
Total return on share price index
1.962 xbrli:pure
1.388 xbrli:pure
1.312 xbrli:pure
1.286 xbrli:pure
0.905 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.